Synchron, a venture-backed brain data transfer company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE)...
Boston-based neurotechnology company Neurable has raised $6 million in Series A funding led by M Ventures. Other participants were Innospark Ventures and existing investors...
Neurable, a Boston-based startup has developed a software that makes it possible for users to control virtual and augmented reality with their mind. In...